Akebia Ends Deal With CSL Vifor, Unveils Hefty Price Tag for CKD Anemia Drug Vafseo
Pictured: Businessman rejecting an offer/iStock, Atstock Productions Akebia Therapeutics on Thursday announced that it has regained full rights to the oral drug Vafseo (vadadustat) for chronic kidney disease anemia after its commercialization partner …